S M de Boer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S M de Boer

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2017

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancerS M de Boer, B G Wortman, T Bosse, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025

Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapyA Corbeau, E Astreinidou, S C Kuipers, et al.

British Journal of Cancer|October 26, 2018

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapyB G Wortman, C L Creutzberg, H Putter, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2017

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancerS M de Boer, B G Wortman, T Bosse, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025

Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapyA Corbeau, E Astreinidou, S C Kuipers, et al.

British Journal of Cancer|October 26, 2018

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapyB G Wortman, C L Creutzberg, H Putter, et al.

Pageof 2